# Lymol Medical Corporation – FDA Inspection, Jun 24, 2016

Source: https://www.keypedia.com/records/fda_inspections/lymol-medical-corporation/ec8f4d44-25fd-4a65-9a46-595698c6d49d
Source feed: FDA_Inspections

> FDA inspection 976447 of Lymol Medical Corporation, June 24, 2016. Classification: Voluntary Action Indicated (VAI). 17 citations under 21 CFR parts 211, 314, 803 and 820. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 976447
- Company Name: Lymol Medical Corporation
- Inspection Date: 2016-06-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 17

## Related Documents

- [FDA Inspection 1147369 - 2021-07-29](https://www.keypedia.com/records/fda_inspections/lymol-medical-corporation/7392a612-994e-427e-bbe8-61ba5300ed8d)
- [FDA Inspection 1117620 - 2020-02-12](https://www.keypedia.com/records/fda_inspections/lymol-medical-corporation/933ff1ee-2777-4d54-9b0c-e5dc8212dcb1)
- [FDA Inspection 759069 - 2011-12-15](https://www.keypedia.com/records/fda_inspections/lymol-medical-corporation/2fd9cd61-e505-425a-9629-ff1098fcd397)
- [FDA Inspection 680212 - 2010-09-14](https://www.keypedia.com/records/fda_inspections/lymol-medical-corporation/f3b30929-5efc-4cf9-9e45-1d930e1146cf)
- [FDA Inspection 596000 - 2009-07-09](https://www.keypedia.com/records/fda_inspections/lymol-medical-corporation/1d8a5bdf-2a74-4a64-ba5b-ac559afad610)

Company: https://www.keypedia.com/companies/lymol-medical-corporation/a98bac62-27b5-4afb-897b-aed3e10e1d9c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c